Skip to content

Nasdaq · CIK 0001841387

CADL Candel Therapeutics, Inc.

Insider trading from SEC Form 4. Last filing Mar 20, 2025. Close $9.94 on Oct 9, 2026, +125% from the 52-week low and -28% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company

Price and insider trades, last year

CADL, daily close, last year. insider buy insider sellDot size follows the dollar value (largest $7.5M).

Signals

Open-market buys and sells at Candel Therapeutics, Inc., scored.

ScoreSideInsiderValueSharesHoldings changePrice contextFiled
14Weaksell 510b5-1Barone Francesca
Chief Scientific Officer
$282k32,146-25%+132% from low · -28% from high
38Weaksell 510b5-1Tak Paul Peter
Chief Executive Officer
$230k26,172-10%+132% from low · -28% from high
21Weaksell 510b5-1Nichols William Garrett
Chief Medical Officer
$397k45,316-46%+132% from low · -28% from high
21Weaksell 510b5-1Schoch Charles
See Remarks
$44k5,000-12%+132% from low · -28% from high
19Weaksell 510b5-1Tyagarajan Seshu
Chief Technology Officer
$276k31,278-27%+132% from low · -28% from high
45Moderatesell 5Barone Francesca
Chief Scientific Officer
$98k13,534-11%+111% from low · -20% from high
43Moderatesell 5Nichols William Garrett
Chief Medical Officer
$75k10,428-12%+111% from low · -20% from high
51Moderatesell 5Tak Paul Peter
Chief Executive Officer
$157k21,704-8%+111% from low · -20% from high
43Moderatesell 5Schoch Charles
See Remarks
$69k9,511-18%+111% from low · -20% from high
45Moderatesell 5Tyagarajan Seshu
Chief Technology Officer
$103k14,322-13%+111% from low · -20% from high
40Moderatesell 5Barone Francesca
Chief Scientific Officer
$112k13,673-10%+130% from low · -12% from high
44Moderatesell 5Nichols William Garrett
Chief Medical Officer
$89k10,799-11%+130% from low · -12% from high
45Moderatesell 5Tyagarajan Seshu
Chief Technology Officer
$120k14,545-12%+130% from low · -12% from high
51Moderatesell 5Tak Paul Peter
Chief Executive Officer
$174k21,172-7%+130% from low · -12% from high
44Moderatesell 5Schoch Charles
See Remarks
$82k9,971-16%+130% from low · -12% from high
50ModeratebuyManning Paul B
director
$7.5M1,250,000+195%-
45Moderatesell 4Barone Francesca
Chief Scientific Officer
$101k22,081-14%-
43Moderatesell 4Nichols William Garrett
Chief Medical Officer
$63k13,935-12%-
57Moderatesell 4Tak Paul Peter
Chief Executive Officer
$223k48,847-14%-
45Moderatesell 4Tyagarajan Seshu
Chief Technology Officer
$93k20,392-14%-
25WeaksellAguilar-Cordova Estuardo
owner
$244k40,412-4%-

Transactions

The last 76 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Mar 18, 2025Barone Francesca
Chief Scientific Officer
MOption exercise
Common Stock10b5-1
+18,000$1.55$28k128,673Mar 20, 2025
Mar 18, 2025Nichols William Garrett
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+4,584$3.75$17k83,904Mar 20, 2025
Mar 18, 2025Tak Paul Peter
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-25,772$8.77$226k226,140Mar 20, 2025
Mar 19, 2025Tak Paul Peter
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-400$9.00$3,601225,740Mar 20, 2025
Mar 18, 2025Nichols William Garrett
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+13,905$1.29$18k97,809Mar 20, 2025
Mar 18, 2025Barone Francesca
Chief Scientific Officer
SOpen-market sale
Common Stock10b5-1
-32,146$8.76$282k96,527Mar 20, 2025
Mar 18, 2025Nichols William Garrett
Chief Medical Officer
SOpen-market sale
Common Stock10b5-1
-45,316$8.76$397k52,493Mar 20, 2025
Mar 18, 2025Barone Francesca
Chief Scientific Officer
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-18,000$0.00$030,822Mar 20, 2025
Mar 18, 2025Nichols William Garrett
Chief Medical Officer
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-4,584$0.00$0195,416Mar 20, 2025
Mar 18, 2025Nichols William Garrett
Chief Medical Officer
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-13,905$0.00$031,095Mar 20, 2025
Mar 17, 2025Schoch Charles
See Remarks
SOpen-market sale
Common Stock10b5-1
-5,000$8.83$44k38,038Mar 19, 2025
Mar 17, 2025Tyagarajan Seshu
Chief Technology Officer
SOpen-market sale
Common Stock10b5-1
-31,278$8.82$276k85,512Mar 19, 2025
Mar 17, 2025Tyagarajan Seshu
Chief Technology Officer
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-20,000$0.00$070,000Mar 19, 2025
Feb 21, 2025Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-10,582$12.02$127k120,861Feb 25, 2025
Feb 21, 2025Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-10,583$12.02$127k162,929Feb 25, 2025
Feb 12, 2025Barone Francesca
Chief Scientific Officer
AGrant or award
Stock Option (Right to Buy)derivative
+115,000$0.00$0115,000Feb 14, 2025
Feb 12, 2025Tak Paul Peter
Chief Executive Officer
AGrant or award
Stock Option (Right to Buy)derivative
+525,000$0.00$0525,000Feb 14, 2025
Feb 12, 2025Nichols William Garrett
Chief Medical Officer
AGrant or award
Stock Option (Right to Buy)derivative
+107,250$0.00$0107,250Feb 14, 2025
Feb 12, 2025Schoch Charles
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+83,000$0.00$083,000Feb 14, 2025
Feb 12, 2025Tyagarajan Seshu
Chief Technology Officer
AGrant or award
Stock Option (Right to Buy)derivative
+65,000$0.00$065,000Feb 14, 2025
Feb 10, 2025Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-31,335$8.61$270k60,000Feb 13, 2025
Jan 15, 2025Tyagarajan Seshu
Chief Technology Officer
SOpen-market sale
Common Stock
-14,322$7.23$103k96,790Jan 17, 2025
Jan 15, 2025Nichols William Garrett
Chief Medical Officer
SOpen-market sale
Common Stock
-10,428$7.23$75k79,320Jan 17, 2025
Jan 15, 2025Schoch Charles
See Remarks
SOpen-market sale
Common Stock
-9,511$7.23$69k43,038Jan 17, 2025
Jan 15, 2025Tak Paul Peter
Chief Executive Officer
SOpen-market sale
Common Stock
-21,704$7.23$157k251,912Jan 17, 2025
Jan 15, 2025Barone Francesca
Chief Scientific Officer
SOpen-market sale
Common Stock
-13,534$7.23$98k110,673Jan 17, 2025
Jan 8, 2025Barone Francesca
Chief Scientific Officer
SOpen-market sale
Common Stock
-13,673$8.22$112k124,207Jan 10, 2025
Jan 8, 2025Nichols William Garrett
Chief Medical Officer
SOpen-market sale
Common Stock
-10,799$8.22$89k89,748Jan 10, 2025
Jan 8, 2025Tyagarajan Seshu
Chief Technology Officer
SOpen-market sale
Common Stock
-14,545$8.22$120k111,112Jan 10, 2025
Jan 8, 2025Tak Paul Peter
Chief Executive Officer
SOpen-market sale
Common Stock
-21,172$8.22$174k273,616Jan 10, 2025
Jan 8, 2025Schoch Charles
See Remarks
SOpen-market sale
Common Stock
-9,971$8.22$82k52,549Jan 10, 2025
Dec 26, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-50,000$9.01$451k223,512Dec 30, 2024
Dec 26, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-50,000$9.01$451k181,443Dec 30, 2024
Dec 27, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-50,000$8.85$443k173,512Dec 30, 2024
Dec 27, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-50,000$8.85$443k131,443Dec 30, 2024
Dec 20, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-100,000$9.00$900k373,512Dec 26, 2024
Dec 20, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-100,000$9.00$900k331,443Dec 26, 2024
Dec 23, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-50,000$8.52$426k323,512Dec 26, 2024
Dec 23, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-50,000$8.52$426k281,443Dec 26, 2024
Dec 24, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
+50,000$8.82$441k273,512Dec 26, 2024
Dec 24, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-50,000$8.82$441k231,443Dec 26, 2024
Dec 16, 2024Manning Paul B
director
POpen-market purchase
Common Stockindirect: By Paul B. Manning Revocable Trust
+500,000$6.00$3.0M1,142,406Dec 18, 2024
Dec 16, 2024Manning Paul B
director
POpen-market purchase
Common Stockindirect: By BKB Growth Investments, LLC
+750,000$6.00$4.5M1,303,752Dec 18, 2024
Dec 11, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-200,000$8.53$1.7M673,512Dec 13, 2024
Dec 11, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-200,000$8.53$1.7M631,443Dec 13, 2024
Dec 12, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-200,000$10.04$2.0M473,512Dec 13, 2024
Dec 12, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-200,000$10.04$2.0M431,443Dec 13, 2024
Dec 4, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-20,000$4.46$89k131,335Dec 6, 2024
Dec 5, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-20,000$4.79$96k111,335Dec 6, 2024
Dec 6, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-20,000$5.23$105k91,335Dec 6, 2024
Nov 29, 2024Barone Francesca
Chief Scientific Officer
SOpen-market sale
Common Stock
-22,081$4.56$101k137,880Dec 3, 2024
Nov 29, 2024Tyagarajan Seshu
Chief Technology Officer
SOpen-market sale
Common Stock
-20,392$4.56$93k125,657Dec 3, 2024
Nov 29, 2024Tak Paul Peter
Chief Executive Officer
SOpen-market sale
Common Stock
-48,847$4.56$223k294,788Dec 3, 2024
Nov 29, 2024Nichols William Garrett
Chief Medical Officer
SOpen-market sale
Common Stock
-13,935$4.56$63k100,547Dec 3, 2024
Nov 25, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-20,000$4.97$99k151,335Nov 27, 2024
Nov 21, 2024Tak Paul Peter
Chief Executive Officer
MOption exercise
Common Stock
+12,900$1.55$20k343,635Nov 21, 2024
Nov 21, 2024Tak Paul Peter
Chief Executive Officer
MOption exercise
Stock Option (Right to Buy)derivative
-12,900$0.00$01,763,968Nov 21, 2024
Nov 6, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-7,500$5.33$40k888,512Nov 8, 2024
Nov 6, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-7,500$5.33$40k846,443Nov 8, 2024
Nov 7, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-7,500$5.19$39k881,012Nov 8, 2024
Nov 7, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-7,500$5.19$39k838,943Nov 8, 2024
Nov 8, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-7,500$4.92$37k873,512Nov 8, 2024
Nov 8, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-7,500$4.92$37k831,443Nov 8, 2024
Oct 30, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-6,000$5.38$32k911,012Nov 1, 2024
Oct 30, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-6,000$5.38$32k868,943Nov 1, 2024
Oct 31, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-7,500$5.30$40k903,512Nov 1, 2024
Oct 31, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-7,500$5.30$40k861,443Nov 1, 2024
Nov 1, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-7,500$5.27$40k896,012Nov 1, 2024
Nov 1, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADLindirect: By LKA 2022 Revocable Trust
-7,500$5.27$40k853,943Nov 1, 2024
Oct 24, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-16,427$5.53$91k903,034Oct 28, 2024
Oct 24, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-1,194$5.72$6,830901,840Oct 28, 2024
Oct 25, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-1,597$5.80$9,263900,243Oct 28, 2024
Oct 28, 2024Aguilar-Cordova Estuardo
owner
DDisposition to issuer
CADL
-11,711$5.58$65k888,532Oct 28, 2024
Oct 11, 2024Aguilar-Cordova Estuardo
owner
SOpen-market sale
CADL
-15,000$6.05$91k944,873Oct 15, 2024
Oct 14, 2024Aguilar-Cordova Estuardo
owner
SOpen-market sale
CADL
-15,000$6.02$90k929,873Oct 15, 2024
Oct 15, 2024Aguilar-Cordova Estuardo
owner
SOpen-market sale
CADL
-10,412$6.03$63k919,461Oct 15, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

CADL insider trading: Candel Therapeutics, Inc. | InsiderTell